Ortho News-eMediNews:Health & Medicine Updates

Thursday, June 20, 2013 | Updated 3:4 IST

http://www.heartcarefoundationofindia.org/

https://www.facebook.com/pages/World-Fellowship-of-Religions/187532511301936

eMedinewS

MTX monotherapy still the treatment of choice in RA

Methotrexate (MTX) is currently the cornerstone in the treatment of rheumatoid arthritis (RA) and recommended as first-line therapy.More...

Febuxostat better for gout in women

A post-hoc analysis looking at urate-lowering therapies in women with gout shows that febuxostat 80 mg daily is more effective than lower doses of
More...

MRI for GOUT Diagnosis

Inexperienced doctors often are reluctant to perform arthrocentesis, and even experienced doctors sometimes fail to obtain fluid via
More...

MTX monotherapy still the treatment of choice in RA

Methotrexate (MTX) is currently the cornerstone in the treatment of rheumatoid arthritis (RA) and recommended as first-line therapy.
More...

Other Ortho News Article

Febuxostat better for gout in women
A post-hoc analysis looking at urate-lowering therapies in women with gout shows that febuxostat 80 mg More »

MRI for GOUT Diagnosis
Inexperienced doctors often are reluctant to perform arthrocentesis, and even experienced doctors sometimes fail to obtain fluid via arthrocentesisMore »

MTX monotherapy still the treatment of choice in RA
Methotrexate (MTX) is currently the cornerstone in the treatment of rheumatoid arthritis (RA) and recommended as first-line therapy.More »

Febuxostat better for gout in women
A post-hoc analysis looking at urate-lowering therapies in women with gout shows that febuxostat 80 mg daily is more More »

MRI for GOUT Diagnosis
Inexperienced doctors often are reluctant to perform arthrocentesis, and even experienced doctors sometimes fail to obtain fluid via arthrocentesis. More »

Message good for low back pains
A randomized trial in 401 patients with chronic nonspecific low back pain found that 10 sessions of More »

Choice of Biologic Not Important in RA
No statistically significant differences emerged in number of responders or in time to therapy response among rheumatoid arthritis patients treated with different biologic agents. A clinically meaningful reduction in RA symptoms More »

Methotrexate-based tight control in early rheumatoid arthritis
A strategy of methotrexate-based tight control in early rheumatoid arthritis (RA) was more effective in preventing joint damage if the initial regimen also included low-dose prednisone. Among More »

Methotrexate monotherapy in RA
Patients with rheumatoid arthritis (RA) who respond well initially to methotrexate monotherapy may be able to maintain a good outcome on that More »

Etanercept r reduces CAD risk
Long-term treatment with the biologic agent etanercept reduces a rheumatoid arthritis patient's risk of heart attack and malignancy, and may also reduce the riskMore »

Early steroids in RA
Treatment of early rheumatoid arthritis with glucosteroids provides relief of symptoms, but the therapy comes with a price – worrisome changes in body fat composition that are significantly increased within the first year. After 12 months of therapy More »

Tanercept monotherapy in RA
Monotherapy with etanercept (Enbrel) can keep some rheumatoid arthritis (RA) patients in long-term remission. Combination therapy with More »

Tanercept monotherapy in RA
Monotherapy with etanercept (Enbrel) can keep some rheumatoid arthritis (RA) patients in long-term remission. Combination therapy with etanercept and methotrexate is considered standard of care for RA but in 34 of 61 patients in More »

Milnacipran for fibromyalgia
Patients with fibromyalgia can achieve long-term pain relief from treatment with the selective serotonin and norepinephrine reuptake inhibitor More »

Tocilizumab monotherapy in RA
Patients with refractory rheumatoid arthritis (RA) responded clinically and radiographically as well to tocilizumab monotherapy as they did to More »

Hydroxychloroquine in SLE
Treatment with hydroxychloroquine among patients with systemic lupus erythematosus was significantly protective against the development of renal failure. In apteints who were not in renal failure at baseline, the use of the More »

MRI may take time to show response in psoriatic arthritis
Not Psoriatic arthritis patients on biologic therapy reported a decrease in pain, but MR imaging of their joints More »